SUMMARY The efficacy of albendazole (50 mg/kg/d), mebendazole (50 mg/kg/d) and praziquantel (500 mg/kg/d) against established intraperitoneal infections of Echinococcus multilocularis in gerbils was compared by monitoring parasite weight and making ultrastructural observations on treated and untreated material. Praziquantel was the most active protoscolicidal agent, reducing protoscolex viability to <2%, although it did not inhibit cyst growth. Albendazole was the most effective agent in reducing cyst growth and was, when compared with other regimes significantly more effective than mebendazole (p<005), praziquantel (p<001) or untreated controls (p<001).
For some years there has been sound experimental' A and increasing clinical evidence4 ' that the benzimidazole carbamate, mebendazole, has at least a parasitostatic effect on E multilocularis. More recently experimental work using albendazole,' another benzimidazole carbamate, and some encouraging preliminary clinical reports"' using the same drug have raised hopes of a possible chemotherapeutic treatment for this disease.
The isoquinoline compound, praziquantel, has been shown to be extremely active against in vitro cultures of E multilocularis protoscoleces and to achieve this effect more rapidly and at lower concentrations than benzimidazole carbamates." We have also shown that praziquantel had some inhibitory effect on in Y,i'o growth of this disease.' The relative efficacies of these two drugs have not been compared with mebendazole, however, and the aim of the present study was therefore to examine the effect of mebendazole, albendazole, and praziquantel against E multiloclularis infections in vivo.
Methods

ANIMALS
Fifty gerbils, which had three months previously received an intraperitoneal injection of -4000 live protoscoleces of E multilocularis suspended in 0-5 ml normal saline, were entered into the experiment. (p=O*l).
It will be seen that the weight gains of differently treated groups of animals closely parallel the weight of parasite material recovered at necropsy. We have previously shown that chemotherapy has little if any effect on the weight of uninfected animals. 9 Ultrastructurally, the germinal layer (Fig. 2 ) and the tegument of protoscoleces (Fig. 3) of hydatids from untreated controls sacrificed at week 25 appeared normal, though occasionally a profile of a dead disintegrating protoscolex was observed, as is customary in established infections.
Material from mebendazole treated animals (Fig. 4 ) differed little from control tissue with the exception of increased vesiculation within the tegumentary cytons which occasionally possessed residual bodies. Brood capsule walls and protoscoleces appeared unaffected and the latter were similar to that illustrated in Fig. 3 .
In albendazole treated tissue, the germinal layer varied from showing increased vesiculation similar to that seen in mebendazole treated material (Fig. 4) to loss of integrity ( Fig. 5) with cyton fragments lying beneath a distal cytoplasm that, in places, was represented only by the truncated microtriches.
Frequently the germinal layer was present only as vesicles and fragmented profiles (Fig. 6) , and the central cavity of such loculi contained vesicular masses and detached protoscolex microtriches. All the examined profiles of intact protoscoleces, however, appeared normal (Fig. 2) , as did the walls of the brood capsules.
Cystic tissue from praziquantel treated animals also varied, often with one loculus appearing little affected apart from slight increased vesiculation and an adjacent loculus showing complete disintegration of the germinal layer (Fig. 7) . Other profiles ranged from substantial loss of integrity of the germinal layer (Fig. 8) , often with mitochondria with atypical cristae, to its total disintegration (Fig. 9) , with only vesicles of the distal cytoplasm remaining in contact with the laminated layer. In all sections that passed through protoscoleces only necrotic tissue was observed.
Discussion
We have previously reported that both the active metabolite of albendazole, albendazole sulphoxide and praziquantel can readily enter the cysts of E mutilocularis9 and are active against the protoscolex in in vitro culture." We have also reported in vivo activity of albendazole against E multilocularis in an animal model. 9 The present study has produced information concerning the in vivo protoscolicidal action of albendazole and prazquantel after therapy, which concurs with the previous in vitro results in that praziquantel was significantly more effective than The efficacy of albendazolc in reducing the ratc of cyst growth, as measured by parasite weight, was greater than either mebendazole at the same dose or praziluantel at 10 times the dosage. Regression of established disease apparently occurred and animal survival was probably enhanced.
The ultrastructural study on albendazole and mebendazole treated tissue concurred with the results obtained by recording parasite weight, and the greater efficacy of albendazole was demonstrated. In contrast, praziquantel did not significantly reduce weight gain even at this high dose of 500 mg/kg/d which is 10 times the dose used in man, yet the majority of profiles observed ultrastructurally showed either loss of integrity or near total disintegration in a manner similar to that reported for Egranulosus. ' Such tissue, although judged dead, would nevertheless contribute to parasite weight at necropsy.
These data are extremely encouraging, though we acknowledge that viable parasite material was present at the end of the experimental period, even in the albendazole treated animals, and this material almost certainly has the ability to resume growth. It is important, however, to note that the animals were treated only daily for five days per week by gavage, and better results might have been achieved using administration systems that would result in consistently higher serum concentrations.
It would, nevertheless, appear that the effect of albendazole is markedly parasitostatic in this gerbil model of established E multilocularis, and perhaps it should now be considered as the drug of choice in the treatment of this lethal disease in man. Whether praziquantel, with is undoubted ability to kill protoscolex, has a role in any clinical setting remains unclear. We have previously demonstrated that combination therapy is more effective than either agent alone for E granlulosius in both in vitro and in vivho systems' and clearly this concept also deserves investigation in this lethal disease. 
